Partnerships and Innovation

From Research to Therapeutic Innovation

The CRCM is committed to a dynamic process of valorization and technology transfer, aiming to transform scientific advances into concrete solutions for patients. Thanks to its unique strengths in translational and clinical research, the CRCM works closely with industrial and institutional partners to accelerate innovation in oncology.

An Ecosystem Dedicated to Technology Transfer

The CRCM and IPC work in synergy with technology transfer organizations specialized in:
• Daily collaboration within the industrial ecosystem
• Management of intellectual property (including patent filing and administration)
• Licensing technologies for rapid industrial application
• Creating start-ups based on research discoveries
• Pre-maturation and maturation programs to foster the emergence of new therapies

We carry out these missions with the support of:

Cutting-Edge Technological Resources: the CoreTech

With 19 integrated technology platforms within CoreTech, the CRCM ensures a direct link between research and clinical application.

These infrastructures make it possible to:

• Generate fundamental discoveries in oncology
• Accelerate the development of new drugs
• Strengthen clinical trials and therapeutic development
• Facilitate patient access to innovations

A Single Point of Access: the IPC4D Program

The IPC4D program, in partnership with the IPC and CRCM, facilitates technology transfer and clinical innovation.
From project identification to preclinical and clinical studies, and all the way through to market authorization, the various CoreTech platforms support all or part of each stage of your project.

In 5 years, Le CoreTech has enabled :

patents filed

software developed

licenses granted

start-up creation

Find out more